All Articles

NexTel Medical acquires two telehealth firms for an instant $135K in monthly revenue, aiming to launch its Maxasome™ exosome therapies to 1,850 clinics.

Static PDFs and fragmented sales pitches are failing. A new class of AI-guided platforms is helping buyers build trust on their own terms. What does this mean?

With FDA clearance for its MagSense® trial, Imagion Biosystems' molecular MRI could change how we see cancer, offering a non-radioactive, high-precision future.

AM Best's negative outlook for a Pennsylvania insurer reveals a deeper crisis. A 16.5% surplus loss from weather is a harbinger for the entire sector.

As Vallarta Supermarkets expands to Merced, it reveals a masterclass in durable growth: a strategy built not on price wars, but on deep community integration.

As Rise Therapeutics advances its oral drug R-2487, it’s not just developing another pill. It’s testing a radical new idea: resetting the immune system.

Railserve's new YardGUARD™ system is more than a safety upgrade. It's a strategic move to rewire industrial rail with integrated, real-time intelligence.

A new platform, Risk Monitor, automates the tracking of permits, community sentiment, and environmental data to help developers stay ahead of project-killing risks.

A small startup just raised $4M to solve the biggest problem in tech: making AR glasses affordable. Their secret isn't a new gadget, but a materials science breakthrough.

EA SPORTS unveils its College Football 27 cover stars, leveraging the NIL era to fuse authenticity with a powerful subscription-driven business model.

Keysight's new RF signal analyzers promise to slash development time for 5G and beyond. But are they the definitive answer to the complexity crisis facing engineers?

The Center for AI Safety recruits xAI's Devin Kim and launches a D.C. institute, signaling a strategic pivot to bridge the gap between AI labs and the Pentagon.

As its CEO heads to a top investor conference, Zealand Pharma leverages AI and novel peptides to challenge giants in the multi-billion-dollar obesity market.

Trillium's sale of its nuclear valve unit to Framatome isn't just a divestment; it's a strategic realignment reshaping the critical infrastructure landscape.

Crosslist moves beyond software with a guide for resellers, a strategic play to capture the booming resale market by teaching the trade before selling the tool.

A new study reveals an 'early warning system' in infant guts, offering a window to combat the atopic march before allergies take hold. Is this the future?

The tech-forward wealth platform is integrating alternative assets, margin, and options, challenging legacy players and democratizing access to elite strategies.

A negative outlook from AM Best reveals deep-seated risks in Colombia, where inflation, political uncertainty, and climate change threaten stability.

By uniting 250 years of heritage, Bradford Labs is not just rebranding. It's building a one-stop-shop to solve the biggest headaches for modern brands.

Method Communications taps veteran Meghan Gardner to lead enterprise tech, a move reflecting a broader industry shift toward deep specialization in the age of AI.